Search

everythinglearnresearchcommunity

for

Search:↓

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Lupus can cause unusual vision problems, so it's important to consider it in such cases.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Leflunomide is more likely to help treat alopecia areata than cause it.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The patient with Ankylosing Spondylitis had shoulder joint damage and bone changes.

Two children with lysinuric protein intolerance showed symptoms similar to lupus.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.